Faropenem is a broad-spectrum penem antibiotic.1 It is active against a panel of 12 Gram-positive (MIC50s = 0.008-1 mg/L) and 15 Gram-negative (MIC50s = 0.06-16 mg/L) bacteria. Faropenem (20 mg/kg) reduces the number of lung colony forming units (CFUs) in a mouse model of H. influenzae-induced respiratory tract infection.2 Formulations containing faropenem have been used in the treatment of various bacterial infections.
1.Schurek, K.N., Wiebe, R., Karlowsky, J.a., et al.Faropenem: Review of a new oral penemExpert Rev. Anti. Infect. Ther.5(2)185-198(2007) 2.Miyazaki, S., Hosoyama, T., Furuya, N., et al.In vitro and in vivo antibacterial activities of L-084, a novel oral carbapenem, against causative organisms of respiratory tract infectionsAntimicrob. Agents Chemother.45(1)203-207(2001)